Not all biopharma pros use social media or want to be contacted out of the blue.
Many biotech marketing agencies get their clients visibility by partnering with media companies and adding a markup. Others may rely on social media or cold calling. These methods not only add more layers of cost — but they can also fall flat.
Your initiatives — and the marketing investments behind them — are too important to be left to chance.
They demand a data-backed platform to reach the right people with the right content. That’s why Endpoints Studio advertising and marketing programs are designed to serve our readers with your unique point of view — delivered in the clear, concise style they expect from Endpoints News.
Choose from a menu of expertly crafted content that’s informed by the real-time searches that bring readers to Endpoints — and what they search for once they’re here.
Endpoints Studio offers a competitive opportunity to learn how readers are engaging with our content so that our partners can plan and optimize future campaigns.
Reach a steadily growing, highly engaged audience that turns to Endpoints News as a habit to learn the latest industry developments and what they mean.
Our readers not only invite us to their email inboxes — but they also come directly to our website or find us through our high search engine rankings.
Studio topics are curated for both broad and niche audiences across biotech and pharma — from cell/gene therapy and manufacturing to Rx marketing and exclusive virtual events. Any topic can be executed across any product in our versatile suite of Studio offerings.See what's currently on deck
Don’t just take it from us. Here’s a sampling of what our partners have had to say about running a campaign across the Endpoints network.
"We also just looked at our website traffic, which increased by 1000% during the Endpoints News week. Naturally, we are super happy with the collaboration and results. In fact, we have generated a number of very interesting leads already."
"We’ve already had an email asking for a meeting based on our ad in the Early Edition report – just getting a single project conversion would make it a good ROI for us!"
"We continue to advertise with Endpoints because they have an engaged, dedicated, and growing biotech readership. This readership is so critical to get in front of for generating awareness for new companies entering the biotech space. Our ads have continuously delivered high impressions and valuable leads – critical to our mission of establishing ourselves as a large player in the industry."
Contact our team to explore how Studio can help you reach your campaign goals